Pulmonary Resection of Non-Small Cell Lung Cancer: Is Survival in the Elderly Not Affected by Tumor Stage after Complete Resection?

被引:11
作者
Boeluekbas, S. [1 ]
Beqiri, S. [1 ]
Bergmann, T. [1 ]
Trainer, S. [1 ]
Fisseler-Eckhoff, A. [2 ]
Schirren, J. [1 ]
机构
[1] Kerckhoff Klin, D-61321 Bad Nauheim, Germany
[2] Dr Horst Schmidt Kliniken GmbH, Inst Pathol & Cytol, Wiesbaden, Germany
关键词
surgery; lung cancer; geriatrics; bronchoplastic resection; sleeve resection; NSCLC;
D O I
10.1055/s-2008-1038963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lung cancer is a disease of the elderly. The aim of this study was to investigate the influence of age on the surgical treatment of non-small cell lung cancer. Methods: We retrospectively reviewed our prospective database of patients older than 75 years of age undergoing pulmonary resection in anatomic units with systematic lymph node dissection for non-small cell lung cancer. Patients were classified as follows: group I (age 75-79 years) and group 11 (age > 80 years). Morbidity, mortality and survival were analyzed in the overall collective and within both groups, respectively. Results: Between January 1999 and December 2004, 157 patients (group I: 110, group II: 47) were enrolled in this study. 104 lobectomies, 8 bilobectomies, 11 pneumonectomies, 15 sleeve resections and 19 segmentectormies were performed. For all resections mortality and morbidity were 3.8% and 38.2%, respectively. There were no significant differences in both groups. The overall 1-year and 5-year survival rates were 83% and 41%. Long-term survival was not affected by tumor stage (p = 0.234) in the present study. Conclusions: Even extended pulmonary resections for non-small cell lung cancer are feasible in the elderly. Long-term survival is obtainable. Tumor stage does not seem to play a role with regard to survival provided that complete resection of the tumor in anatomic units with systematic, extensive lymph node dissection is performed. Further investigations are necessary to prove this hypothesis in larger series.
引用
收藏
页码:476 / 481
页数:6
相关论文
共 25 条
[1]  
[Anonymous], SEER CANC STAT REV 1
[2]   Pulmonary complications after surgical treatment of lung cancer in octogenarians [J].
Aoki, T ;
Yamato, Y ;
Tsuchida, M ;
Watanabe, T ;
Hayashi, J ;
Hirono, T .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (06) :662-665
[3]   Induction chemotherapy with carboplatin-paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer [J].
Ardizzoni, A ;
Scolaro, T ;
Mereu, C ;
Cafferata, MA ;
Tixi, L ;
Bacigalupo, A ;
Tiseo, M ;
Monetti, F ;
Rosso, R .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (01) :58-64
[4]  
BEASLEY MB, 2004, WHO CLASSIFICATION T, P59
[5]   Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: A 22-year experience [J].
Brock, MV ;
Kim, MP ;
Hooker, CM ;
Alberg, AJ ;
Jordan, MM ;
Roig, CM ;
Xu, L ;
Yang, SC .
ANNALS OF THORACIC SURGERY, 2004, 77 (01) :271-277
[6]   The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival [J].
Cerfolio, RJ ;
Bryant, AS ;
Ohja, B ;
Bartolucci, AA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (01) :151-159
[7]   A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly [J].
Chen, Yuh-Min ;
Perng, Reury-Perng ;
Tsai, Chun-Ming ;
Whang-Peng, Jacqueline .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) :141-145
[8]   Incomplete resection of lung cancer: morbidity and prognosis [J].
Dienemann, H ;
Trainer, C ;
Hoffmann, H ;
Bulzebruck, H ;
Muley, T ;
Kayser, K ;
VogtMoykopf, I .
CHIRURG, 1997, 68 (10) :1014-1019
[9]   Lung cancer in octogenarians: Factors affecting morbidity and mortality after pulmonary resection [J].
Dominguez-Ventura, Alberto ;
Allen, Mark S. ;
Cassivi, Stephen D. ;
Nichols, Francis C., III ;
Deschamps, Claude ;
Pairolero, Peter C. .
ANNALS OF THORACIC SURGERY, 2006, 82 (04) :1175-1179
[10]   Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC) [J].
Ferrigno, D ;
Buccheri, G .
LUNG CANCER, 2004, 45 (03) :373-380